Get the latest news on coronavirus impacts on general aviation, including what AOPA is doing to protect GA, event cancellations, advice for pilots to protect themselves, and more. Read More
Already a member? Please login below for an enhanced experience. Not a member? Join today
Menu

New drug for diabetics cleared for use by pilotsNew drug for diabetics cleared for use by pilots

New drug for diabetics cleared for use by pilots

By AOPA ePublishing staff

Is Januvia on your list of medications? If so, the FAA recently announced that pilots can use this new treatment for Type II diabetes.

Januvia, the brand name for sitagliptin phosphate, prolongs the activity of certain proteins that increase the release of insulin when blood sugar increases, such as after a meal. Januvia can be used alone or in combination with other oral diabetes medications.

Pilots who have received a denial letter from the FAA after reporting the use of this drug are now eligible for reconsideration. A status report from your treating physician and a current A1C hemoglobin test result are necessary.

Questions? Contact AOPA's medical certification staff at 800/USA-AOPA or by e-mail.

October 25, 2007

AOPA ePublishing staff

AOPA ePublishing Staff editors are experienced pilots, flight instructors, and aircraft owners who have a passion for bringing you the latest news and AOPA announcements.

Related Articles